1Q21 AND 1P32 [MULTIPLE MYELOMA] (SDL10013)
This test evaluates 1q21 amplification and 1p32 deletion in multiple myeloma using FISH. These genetic changes indicate high-risk disease, guiding prognosis and treatment decisions for personalized management.